Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$40.65 - $65.76 $7,235 - $11,705
-178 Reduced 5.73%
2,926 $140,000
Q3 2023

Nov 14, 2023

BUY
$54.2 - $71.67 $14,796 - $19,565
273 Added 9.64%
3,104 $203,000
Q2 2023

Aug 10, 2023

BUY
$56.23 - $71.17 $13,888 - $17,578
247 Added 9.56%
2,831 $164,000
Q1 2023

May 15, 2023

SELL
$53.43 - $68.12 $21,211 - $27,043
-397 Reduced 13.32%
2,584 $159,000
Q4 2022

Jun 14, 2023

BUY
$61.23 - $83.62 $24,308 - $33,197
397 Added 15.36%
2,981 $189 Million
Q4 2022

Mar 30, 2023

BUY
$61.23 - $83.62 $4,286 - $5,853
70 Added 2.4%
2,981 $189,000
Q4 2022

Feb 15, 2023

BUY
$61.23 - $83.62 $4,286 - $5,853
70 Added 2.4%
2,981 $189,000
Q3 2022

Jun 14, 2023

BUY
$65.58 - $84.69 $21,444 - $27,693
327 Added 12.65%
2,911 $211 Million
Q2 2022

Jun 20, 2023

BUY
$52.13 - $93.81 $17,046 - $30,675
327 Added 12.65%
2,911 $197,000
Q2 2022

Mar 30, 2023

BUY
$52.13 - $93.81 $36,438 - $65,573
699 Added 31.6%
2,911 $197,000
Q2 2022

Aug 11, 2022

BUY
$52.13 - $93.81 $36,438 - $65,573
699 Added 31.6%
2,911 $198,000
Q1 2022

Jun 20, 2023

SELL
$64.92 - $99.47 $24,150 - $37,002
-372 Reduced 14.4%
2,212 $200,000
Q1 2022

Mar 30, 2023

SELL
$64.92 - $99.47 $428,731 - $656,899
-6,604 Reduced 74.91%
2,212 $200,000
Q1 2022

May 12, 2022

SELL
$64.92 - $99.47 $428,731 - $656,899
-6,604 Reduced 74.91%
2,212 $200,000
Q4 2021

Jun 21, 2023

BUY
$76.51 - $93.96 $476,810 - $585,558
6,232 Added 241.18%
8,816 $804,000
Q4 2021

Mar 30, 2023

SELL
$76.51 - $93.96 $41,544 - $51,020
-543 Reduced 5.8%
8,816 $804,000
Q4 2021

Feb 15, 2022

SELL
$76.51 - $93.96 $41,544 - $51,020
-543 Reduced 5.8%
8,816 $805,000
Q3 2021

Jun 21, 2023

BUY
$71.29 - $95.99 $482,989 - $650,332
6,775 Added 262.19%
9,359 $759,000
Q3 2021

Mar 30, 2023

BUY
$71.29 - $95.99 $356 - $479
5 Added 0.05%
9,359 $759,000
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $356 - $479
5 Added 0.05%
9,359 $759,000
Q2 2021

Jun 21, 2023

BUY
$79.62 - $114.85 $539,027 - $777,534
6,770 Added 262.0%
9,354 $872,000
Q2 2021

Mar 30, 2023

BUY
$79.62 - $114.85 $376,522 - $543,125
4,729 Added 102.25%
9,354 $872,000
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $744,367 - $1.07 Million
9,349 Added 186980.0%
9,354 $873,000
Q1 2021

Jun 26, 2023

BUY
$77.91 - $125.92 $159,014 - $257,002
2,041 Added 78.99%
4,625 $495 Million
Q1 2021

Mar 30, 2023

BUY
$77.91 - $125.92 $178,102 - $287,853
2,286 Added 97.73%
4,625 $494,000
Q1 2021

May 14, 2021

SELL
$77.91 - $125.92 $181,841 - $293,897
-2,334 Reduced 99.79%
5 $495,000
Q4 2020

Jun 22, 2023

SELL
$60.0 - $87.29 $14,700 - $21,386
-245 Reduced 9.48%
2,339 $204,000
Q3 2020

Jun 26, 2023

SELL
$47.53 - $82.76 $11,644 - $20,276
-245 Reduced 9.48%
2,339 $161,000
Q3 2020

Mar 30, 2023

SELL
$47.53 - $82.76 $30,514 - $53,131
-642 Reduced 21.54%
2,339 $161,000
Q3 2020

Nov 13, 2020

BUY
$47.53 - $82.76 $111,172 - $193,575
2,339 New
2,339 $161,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.